Because valdecoxib (the
metabolite of parecoxib) increases dextromethorphan levels by about 3-fold the manufacturers predict that the levels of
flecainide (which is similarly metabolised) will also be raised by valdecoxib.
The general importance of this interaction is unclear, but be aware that the effects of
flecainide may be increased.